Patents by Inventor Arun K. Bahl

Arun K. Bahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFIED BETA GLUCAN COMPOSITION
    Publication number: 20110195926
    Abstract: The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
    Type: Application
    Filed: August 13, 2010
    Publication date: August 11, 2011
    Applicant: ImmuDyne, Inc.
    Inventors: Arun K. Bahl, Sharon V. Vercellotti, John R. Vercellotti, Elias Klein
  • IMMUNOPOTENTIATING AGENT FOR USE IN ANIMALS
    Publication number: 20100279979
    Abstract: A simplified method for producing an immunopotentiating agent from cell walls of yeast, other fungi or bacteria is provided and its use as an additive to animal feed to increase resistance to various infections and to potentiate the effect of vaccines is described.
    Type: Application
    Filed: September 18, 2008
    Publication date: November 4, 2010
    Inventors: Nino Sorgente, Philip A. Courier, Jr., Amy J. Miles, Arun K. Bahl
  • Purified beta glucan composition
    Patent number: 7777027
    Abstract: The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: August 17, 2010
    Assignee: Immudyne, Inc.
    Inventors: Arun K. Bahl, Sharon V. Vercellotti, John R. Vercellotti, Elias Klein
  • Methods of purifying beta glucans
    Patent number: 7550584
    Abstract: The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
    Type: Grant
    Filed: March 27, 2006
    Date of Patent: June 23, 2009
    Assignee: Immudyne, Inc.
    Inventors: Arun K. Bahl, Sharon V. Vercellotti, John R. Vercellotti, Elias Klein
  • Purified Beta Glucan Composition
    Publication number: 20080200429
    Abstract: The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
    Type: Application
    Filed: April 14, 2008
    Publication date: August 21, 2008
    Inventors: Arun K. Bahl, Sharon V. Vercellotti, John R. Vercellotti, Elias Klein
  • Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
    Patent number: 7018986
    Abstract: The invention provides methods of using beta glucans to treat conditions associated with bone loss or low bone density as well as methods for promoting bone growth in situations where enhanced bone growth is desirable. In the invention methods beta glucans are administered so as to enhance the development of osteoblasts and the inhibition of the development and recruitment of osteoclasts. The inhibition of the recruitment and development of osteoclasts, coupled with the enhancement of osteoblast maturation by beta glucans leads to decreased bone resorption and increased bone formation, making beta glucans ideal agents for the treatment of osteoporosis and other bone resorption diseases.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: March 28, 2006
    Assignee: Immudyne
    Inventors: Nino Sorgente, Harald L. Guenther, Hannelore E. Guenther, Arun K. Bahl